• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Academy
  • FAQ
  • News
  • Blog
  • Europe
    • United Kingdom
    • Spain
    • Italy
    • Portugal
    • Brazil
    • Colombia
    • Ecuador
    • Mexico
    • Argentina
    • Latin America
    • UAE
Veritas

Veritas

  • Services and Test
        • Preventive Medicine
          • myGenome
          • myGeneticRisk
          • myHealthScore
          • myPharma
        • Perinatal Medicine
          • myPrenatal
          • myNewborn
          • myBabyHealth
          • PregnancyLoss
          • PrenatalWES
        • Diagnostic Genetics Services
          • CardioRisk
          • CancerRisk
          • GenomeDx
          • ExomeDx
          • Targeted Panels
        • Genetic Counselling
          • Genetic Counselling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • CONTACT
LlámanosLlámanos
CALL US!
  • Europe

  • United Kingdom

  • Spain

  • Italy

  • Brazil

  • Portugal

  • Colombia

  • Ecuador

  • Mexico

  • Argentina

  • Latin America

  • Services & Test
    • Preventive Medicine
      • myGenome
      • myGeneticRisk
      • myHealthScore
    • Pregnancy & Early Childhood
      • myPrenatal
      • myNewborn
      • myBabyHealth
      • PregnancyLoss
    • Genetics Diagnostics
      • CardioRisk
      • CancerRisk
      • GenomeDx
      • ExomeDx
      • Targeted Panels
    • Genetic Counseling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • Academy
  • FAQ
  • News
  • Blog
  • Contact

PrenatalWES

PrenatalWES

One test, all the power of genetic diagnostics (deletions/duplications and molecular testing)

PrenatalWES is an innovative prenatal diagnostic test indicated in pregnancies with ultrasound findings with suspected genetic alteration. It consists of sequencing the fetal exome from amniocentesis or chorionic villus sampling for the study of CNVs and other genetic alterations.

The test is especially indicated in:

Diagnostic service aimed at pregnant women in the following situations

Enlarged nuchal fold, after ruling out aneuploidy

Cardiac malformation

Short femur

IUGR, after ruling out aneuploidy

Veritas offers in a single test a complete prenatal diagnostic service, based on fetal exome sequencing, which includes both Copy Number Variants (CNVs) and targeted analysis of single nucleotide variants (SNVs) based on diagnostic suspicion.

Advantages

PrenatalWES brings advantages at different levels:

From a single invasive procedure and single sample it is possible to perform CNVs analysis and molecular studies.

The turnaround time is shortened as the foetal exome sequencing is performed and if a subsequent molecular analysis is needed, only the data analysis is necessary.

In foetuses with a normal result, it is possible to order neonatal screening tests after birth, obtaining a much faster result (myNewborn).

The information obtained from a single sample is maximised.

Are you interested in PrenatalWES but you do not have a doctor that provides the service?

Our medical professionals can help you. Contact us.

FIND OUT MORE

Advice to the specialist

Veritas offers a differential service by providing advice to the specialist for the interpretation of your patient’s results, whenever you need it.

Are you a medical professional?

If you want more technical information about PrenatalWES you can download it here

DOWNLOAD

Footer

  • facebook
  • youtube
  • twitter
  • instagram
  • linkedin

VERITAS INTERCONTINENTAL – CALLE ORENSE 58, 2ºC-D, 28020 MADRID, ESPAÑA – CIF B88132907 – AUTHORIZED MEDICAL CENTER Registration Nº CS20242

  • Privacy policy and Legal Notice
  • General contracting conditions
  • Cookies Policy